Implantable device research from the BrainGate clinical trial enables communication through rapid typing for a patient with ...
On March 11, 2026, USPTO Director John Squires issued a memorandum establishing new discretionary factors for the institution of inter partes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results